KBC Group’s Elevance Health ELV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $23.6M | Sell |
60,914
-1,809
| -3% | -$671K | 0.05% | 258 |
|
|
2026
Q1 | $18.4M | Sell |
62,723
-15,256
| -20% | -$5.01M | 0.05% | 278 |
|
|
2025
Q4 | $27.3M | Sell |
77,979
-34,367
| -31% | -$11.6M | 0.06% | 233 |
|
|
2025
Q3 | $36.3M | Sell |
112,346
-1,381
| -1% | -$430K | 0.09% | 194 |
|
|
2025
Q2 | $44.2M | Sell |
113,727
-251,625
| -69% | -$101M | 0.12% | 162 |
|
|
2025
Q1 | $159M | Sell |
365,352
-102,359
| -22% | -$41.1M | 0.49% | 34 |
|
|
2024
Q4 | $173M | Buy |
467,711
+192,156
| +70% | +$80.4M | 0.48% | 32 |
|
|
2024
Q3 | $143M | Sell |
275,555
-22,057
| -7% | -$11.8M | 0.43% | 40 |
|
|
2024
Q2 | $161M | Buy |
297,612
+13,527
| +5% | +$7.15M | 0.49% | 29 |
|
|
2024
Q1 | $147M | Buy |
284,085
+35,709
| +14% | +$17.8M | 0.47% | 42 |
|
|
2023
Q4 | $117M | Buy |
248,376
+21,291
| +9% | +$9.85M | 0.42% | 53 |
|
|
2023
Q3 | $98.9M | Buy |
227,085
+16,633
| +8% | +$7.54M | 0.4% | 53 |
|
|
2023
Q2 | $93.5M | Sell |
210,452
-8,297
| -4% | -$3.83M | 0.38% | 59 |
|
|
2023
Q1 | $101M | Buy |
218,749
+17,780
| +9% | +$8.46M | 0.43% | 54 |
|
|
2022
Q4 | $103M | Sell |
200,969
-51,834
| -21% | -$26.3M | 0.5% | 41 |
|
|
2022
Q3 | $115M | Sell |
252,803
-69,728
| -22% | -$33.4M | 0.6% | 37 |
|
|
2022
Q2 | $156M | Buy |
322,531
+17,348
| +6% | +$8.58M | 0.78% | 26 |
|
|
2022
Q1 | $150M | Sell |
305,183
-124,282
| -29% | -$56.8M | 0.59% | 39 |
|
|
2021
Q4 | $199M | Buy |
429,465
+11,497
| +3% | +$4.84M | 0.66% | 33 |
|
|
2021
Q3 | $156M | Buy |
417,968
+20,053
| +5% | +$7.62M | 0.57% | 36 |
|
|
2021
Q2 | $152M | Sell |
397,915
-36,480
| -8% | -$13.9M | 0.55% | 38 |
|
|
2021
Q1 | $156M | Buy |
434,395
+17,989
| +4% | +$5.78M | 0.63% | 29 |
|
|
2020
Q4 | $134M | Buy |
416,406
+71,746
| +21% | +$22M | 0.62% | 29 |
|
|
2020
Q3 | $92.6M | Buy |
344,660
+93,286
| +37% | +$25.1M | 0.55% | 38 |
|
|
2020
Q2 | $66.1M | Buy |
251,374
+24,791
| +11% | +$6.61M | 0.44% | 43 |
|
|
2020
Q1 | $51.4M | Buy |
226,583
+67,228
| +42% | +$18.3M | 0.43% | 47 |
|
|
2019
Q4 | $48.1M | Sell |
159,355
-3,486
| -2% | -$959K | 0.3% | 67 |
|
|
2019
Q3 | $39.1M | Buy |
162,841
+69,071
| +74% | +$18.9M | 0.29% | 73 |
|
|
2019
Q2 | $26.5M | Sell |
93,770
-619
| -0.7% | -$169K | 0.2% | 124 |
|
|
2019
Q1 | $27.1M | Sell |
94,389
-1,972
| -2% | -$570K | 0.22% | 103 |
|
|
2018
Q4 | $25.3M | Sell |
96,361
-31,895
| -25% | -$8.77M | 0.28% | 82 |
|
|
2018
Q3 | $35.1M | Sell |
128,256
-6,925
| -5% | -$1.8M | 0.27% | 94 |
|
|
2018
Q2 | $32.2M | Sell |
135,181
-51,945
| -28% | -$12M | 0.28% | 87 |
|
|
2018
Q1 | $41.1M | Buy |
187,126
+90,095
| +93% | +$21.2M | 0.38% | 63 |
|
|
2017
Q4 | $21.8M | Buy |
97,031
+1,356
| +1% | +$289K | 0.19% | 141 |
|
|
2017
Q3 | $18.2M | Sell |
95,675
-18,005
| -16% | -$3.43M | 0.16% | 149 |
|
|
2017
Q2 | $21.4M | Buy |
113,680
+5,582
| +5% | +$1M | 0.21% | 133 |
|
|
2017
Q1 | $17.9M | Sell |
108,098
-23,945
| -18% | -$3.81M | 0.16% | 155 |
|
|
2016
Q4 | $19M | Sell |
132,043
-112,356
| -46% | -$15M | 0.19% | 130 |
|
|
2016
Q3 | $30.6M | Buy |
244,399
+81,966
| +50% | +$10.6M | 0.36% | 64 |
|
|
2016
Q2 | $21.3M | Buy |
162,433
+88,741
| +120% | +$12.1M | 0.31% | 78 |
|
|
2016
Q1 | $10.2M | Sell |
73,692
-36,346
| -33% | -$4.86M | 0.17% | 159 |
|
|
2015
Q4 | $15.3M | Sell |
110,038
-69,319
| -39% | -$9.55M | 0.28% | 91 |
|
|
2015
Q3 | $25.1M | Sell |
179,357
-85,802
| -32% | -$12.9M | 0.51% | 37 |
|
|
2015
Q2 | $43.5M | Buy |
265,159
+10,130
| +4% | +$1.62M | 0.56% | 27 |
|
|
2015
Q1 | $39.4M | Sell |
255,029
-45,032
| -15% | -$6.41M | 0.5% | 39 |
|
|
2014
Q4 | $37.7M | Buy |
300,061
+286,806
| +2,164% | +$35.4M | 0.45% | 43 |
|
|
2014
Q3 | $1.59M | Sell |
13,255
-311,382
| -96% | -$35.7M | 0.06% | 396 |
|
|
2014
Q2 | $34.9M | Buy |
324,637
+204,787
| +171% | +$21.1M | 0.4% | 45 |
|
|
2014
Q1 | $11.9M | Sell |
119,850
-104,819
| -47% | -$9.48M | 0.19% | 130 |
|
|
2013
Q4 | $20.8M | Sell |
224,669
-105,416
| -32% | -$9.37M | 0.31% | 72 |
|
|
2013
Q3 | $27.6M | Buy |
330,085
+46,240
| +16% | +$3.96M | 0.44% | 46 |
|
|
2013
Q2 | $23.2M | Buy |
+283,845
| New | +$21.2M | 0.43% | 48 |
|
Other funds holding ELV
KBC Group's ELV Position: Q2 2026 in Review
KBC Group reduced its Elevance Health (ELV) stake by 2.9% in Q2 2026, selling an estimated $671K and leaving 60,914 shares worth $23.6M. The position accounts for 0.05% of the portfolio, ranked #258.
KBC Group first reported a position in ELV in Q2 2013 and has held it in 53 quarters since. The position peaked at $199M in Q4 2021. 1,609 funds tracked by Wall St. Rank hold ELV as of Q2 2026.
- KBC Group held 60,914 shares of Elevance Health worth $23.6M as of Q2 2026.
- KBC Group sold 1,809 Elevance Health shares in Q2 2026, an estimated $671K.
- Elevance Health made up 0.05% of KBC Group's portfolio in Q2 2026, its #258 holding.
- KBC Group first reported a position in Elevance Health in Q2 2013 and has held it in 53 quarters since.
- KBC Group's Elevance Health position peaked at $199M in Q4 2021.
- 1,609 funds tracked by Wall St. Rank held Elevance Health as of Q2 2026.
Based on KBC Group's 13F filing for Q2 2026, filed 5 Aug 2026.